![Figure 8: Major analytical performance measurements of the NeXT Personal® assay.](https://www.oncotarget.net/wp-content/uploads/2024/03/Screen-Shot-2024-03-20-at-2.22.00-PM-300x161.png)
Analytical Validation of an Ultra-sensitive Personalized Circulating Tumor DNA Assay: NeXT Personal®
March 20, 2024
These results suggest strong potential for clinical use of the assay in ctDNA monitoring of solid tumor cancers.”BUFFALO, NY- March 20, 2024 – A new research paper was published in... read more